Anti-inflammatory androstane derivative compositions
US6777399B2 · kind B2 · utility
9Cited by
40References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2002 |
| Grant date | Aug 17, 2004 |
| Priority date | — |
| Expiry date | May 24, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a crystalline chemical composition comprising a compound of formula (I) in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in the crystalline composition is of space group P212121 having unit cell dimensions of about 12.1±0.6 å, 14.9±0.7 å, and 16.2±0.8 å when determined at either 120K or 150K.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.